Prosztatarák: vizsgálatok itt: India
8 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleA Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
- Where
- Amravati, Bengaluru, Bhubaneswar, Gorimedu, Hyderabad, Jaipur, Kochi, Kolkata, Mumbai, Nadiād, New Delhi, Thiruvananthapuram, Varanasi, Vellalasseri
- Életkor
- 18 év and over
- People
- 50
- Run by
- Bayer
See details and how to joinNCT05348876 - No phaseNot yet taking people in IndiaA Study of Darolutamide Plus Androgen Deprivation Therapy in Patients With Metastatic Hormone-sensitive Prostate Cancer in India
- Where
- Multiple Locations
- Életkor
- 18 év and over
- People
- 60
- Run by
- Bayer
See details and how to joinNCT07806591 - 3. fázisTaking peopleAZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Where
- Bangalore, Gūrgaon, Navi Mumbai
- Életkor
- 18 év and over
- People
- 670 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07611110 - 3. fázisTaking peopleStudy Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Where
- Bengaluru, Gurgaon, Mumbai
- Életkor
- 18 év to 100 év
- People
- 940 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06855277 - 3. fázisTaking peopleSaruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
- Where
- Ansārinagar, Bangalore, Delhi, Kannur, Nagpur, New Delhi, Vadodara
- Életkor
- 18 év and over
- People
- 1330 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07711002 · EU 2026-526275-38-00 - 3. fázisTaking peopleA Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Where
- Ansārinagar, Babgalore, Calicut, Delhi, Hyderabad, Kannur, Kanpur, Mumbai, Nagpur, Varanasi
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06952803 · EU 2024-513586-39-00 - 2. fázisNot yet taking people in IndiaA Study Testing if Patients With Advanced Prostate Cancer Who Are Responding Well to Combination Treatment Can Safely Reduce Their Medication to a Single Hormone Therapy, Compared to Continuing Their Current Drugs
- Where
- Mumbai
- Életkor
- 18 év to 80 év
- People
- 170
- Run by
- Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute
See details and how to joinNCT07838753 - 2. fázisTaking peopleReduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial
- Where
- Mumbai
- Életkor
- 19 év to 99 év
- People
- 206
- Run by
- Tata Memorial Centre
See details and how to joinNCT06818682